Syrna Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Syrna Therapeutics is pioneering small molecules that covalently modify mRNA to selectively reduce expression of disease-causing proteins in the body.
Syrna raised a $10M seed round in 2023 co-lead by Insight Partners and Innovation Endeavors. Syrna is currently stealth and does not have a website or linked-in presence. For inquiries, please contact David Weitz, Founder and CEO at david.weitz@syrnatx.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}